Adherence to Continuous Positive Airway Pressure Hugely Improved during COVID-19 Lockdown in France

Publié par Jean-Louis Pépin, en 2021 - AJRCCM

The impact of the coronavirus disease (COVID-19) pandemic on adherence to chronic therapies is still debated and potential concerns have been raised regarding its effect on the short- and long-term outcomes of chronic diseases (1, 2). During the pandemic, access to routine care has been restricted as resources have been reallocated, prioritizing the response to COVID-19. In addition, nationwide home confinement has been extensively used to prevent the spread of COVID-19 infection, leading in some individuals to a deterioration in their mental health, greater anxiety, and unhealthy behaviors that might have impacted adherence to chronic therapies

Retour en haut